Trial intelligence / Profile preview

IP Granisetron for Postoperative Pain in Laparoscopic Cholecystectomy

NCT06281418Phase 3Completed

Sponsor
Future University in Egypt
Start
Feb 2024
Primary completion
Dec 2024
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of granisetron in postoperative pain (2 arms), sponsored by Future University in Egypt. Primary endpoint: Visual Analog Scale at 24 hours. Started Feb 2024; status: completed.

02

Drugs

granisetron
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT06281418.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06281418.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call